RPS6KA1 and lung cancer: However, also in lung cancer, RSK1 has been shown to be a tumor suppressor since its depletion increased cell motility and enhanced metastatic potential, whereas RSK4 depletion had the opposite impact and was acting as a pro-cancerous agent (52).